Cart
sales@molnova.com
Pridefine
CAS No. 5370-41-2
Pridefine( —— )
Catalog No. M34018 CAS No. 5370-41-2
Pridefine (Pridefina) is a pyrrolidine derivative, a reuptake blocker of catecholamines and serotonin, with antidepressant activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 411 | In Stock |
|
| 10MG | 562 | In Stock |
|
| 25MG | 866 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePridefine
-
NoteResearch use only, not for human use.
-
Brief DescriptionPridefine (Pridefina) is a pyrrolidine derivative, a reuptake blocker of catecholamines and serotonin, with antidepressant activity.
-
DescriptionPridefine (AHR-1118) is an antidepressant agent.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
Target5-HT Receptor
-
Recptor5-HT Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number5370-41-2
-
Formula Weight263.38
-
Molecular FormulaC19H21N
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC=1C=CC(=CC1)C(C=2C=CC=CC2)=C3CN(CC)CC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Vosmer G, et al. Action of the antidepressant pridefine (AHR-1118) on biogenic amines in the rat brain. Biochem Pharmacol. 1980 Oct 1;29(19):2557-62.?
molnova catalog
related products
-
Naluzotan hydrochlor...
Naluzotan hydrochloride (PRX 00023 hydrochloride) is a hERG K+ channel blocker with an IC50 value of 3800 nM and is commonly used in the study of anxiety and depression.
-
Seganserin
Seganserin, a non-selective 5-hydroxytryptamine 2-HT receptor antagonist, reversed the inhibitory effects of fluoxetine and quipazine on luteinizing hormone-induced hyperphagia, depression and nociception, and reversed the antidepressant and analgesic effects induced by fluoxetine and quipazine.
-
Liafensine
Liafensine(BMS-820836) is a novel and selective triple monoamine reuptake inhibitor with inhibitory effects on the reuptake of serotonin, norepinephrine, and dopamine for the study of major depressive disorder and central nervous system disorders.
